Outcomes for blunt aortic injury study cohort (N=427), by repair type
| Outcome (no, %) | TEVAR n=105 (no, %) | Surgical repair n=22 (no, %) | Hybrid repair n=49, (no, %) | Medical management n=251 (no, %) | All patients n=427 (no, %) | P value |
| Survival to maximum follow-up | 83 (79.0) | 14 (63.6) | 42 (85.7) | 209 (83.3) | 348 (81.5) | 0.10 |
| Aorta-related mortality | 1–5* | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1–5* | 0.38 |
| Aortic reintervention | 6 (5.7) | 1–5* | 1–5* | 0 (0.0) | 11 (2.6) | <0.01 |
| Stroke | 1–5* | 0 (0.0) | 1–5* | 6 (2.4) | 9 (2.1) | 0.90 |
| Spinal cord ischemia | 1–5* | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1–5* | 0.38 |
| Endoleak | 1–5* | 1–5* | 0 (0.0) | 1–5* | 1–5* | 0.14 |
| Chronic renal failure with dialysis | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1–5* | 1–5* | 0.70 |
*Cells with less than six patients are suppressed to protect patient privacy.
TEVAR, thoracic endovascular aortic repair.